We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi and Translate Bio Team Up on mRNA-based COVID-19 Vaccine Candidate
Sanofi and Translate Bio Team Up on mRNA-based COVID-19 Vaccine Candidate
Sanofi Pasteur and Translate Bio are working together on a COVID-19 vaccine candidate that uses messenger-RNA (mRNA) technology and should be easier to store than Moderna’s and Pfizer/ BioNTech’s mRNA-based vaccines.